Saturday, June 20, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 835 of 1,261

  1. US 8623832

    Peptide compositions that bind TLR-4

    The Board of Regents of the University of Oklahoma · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  2. US 8623814

    Antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  3. US 8623828

    Blocking mesothelin peptide fragments

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  4. US 8623841

    Medical and nutritional applications of highly refined cellulose

    Regents of the University of Minnesota · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  5. US 8623894

    Solid forms of N-[2,4-Bis(1,1-dimethyethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquioline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  6. US 8623915

    Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

    Esperion Therapeutics, Inc. · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  7. US 8623867

    Cyclic amine BACE-1 inhibitors having a benzamide substituent

    Pharmacopeia Drug Discovery, Inc. · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  8. US 8623869

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  9. US 8622920

    Breath test device and method

    EXALENZ BIOSCIENCE LTD. · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  10. US 8623371

    Targeting poly-gama-glutamic acid to treat Staphylococcus epidermidis and related infections

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  11. US 8623383

    Recombinant antigens for diagnosis and prevention of spotted fever rickettsiae

    United States of America as represented by the Secretary of the Air Force · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  12. US 8623330

    Emollient foams for treatment of seborrheic dermatitis

    Precision Dermatology, Inc. · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  13. US 8624032

    Compound libraries made through phosphine-catalyzed annulation/Tebbe/Diels-Alder reactions

    The Regents of the University of California · Granted Jan 7, 2014 · Expires Jan 2, 2034

    granted

  14. EP 2678011

    ANTITUMORIGENE KOMBINATON, DIE CABAZITAXEL UND CISPLATIN UMFASST

    AVENTIS PHARMA SA [FR] · Granted Jan 1, 2014 · Expires Dec 27, 2033

    granted

  15. US 8618290

    HSP90 inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  16. US 8617815

    Molecules with effects on cellular development and function

    The Regents of the University of California · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  17. US 8618106

    Protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  18. US 8618095

    2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses

    Rigel Pharmaceuticals, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  19. US 8618152

    Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases

    Vertex Pharmaceuticals Incorporated · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  20. US 8618331

    Polycyclic heteroaryl substituted triazoles useful as axl inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  21. US 8617530

    Polymer conjugates of opioid antagonists

    Nektar Therapeutics · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  22. US 8617600

    Modified release preparations containing oxcarbazepine and derivatives thereof

    Supernus Pharmaceuticals, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  23. US 8618324

    Composition and method for making oligo-benzamide compounds

    The Board of Regents of the University of Texas System · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

  24. US 8618270

    Oligonucleotide analog and method for treating flavivirus infections

    Sarepta Therapeutics, Inc. · Granted Dec 31, 2013 · Expires Dec 26, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.